Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. IMRN
IMRN logo

IMRN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IMRN News

Immuron CEO to Present at Coffee Microcaps Conference

Mar 05 2026Newsfilter

Immuron Reports Record Half-Year Sales of A$4.2 Million

Feb 25 2026seekingalpha

Immuron Reports Strong H1 FY26 Financial Results and Strategic Developments

Feb 25 2026Newsfilter

B. Riley Financial Shares Surge Approximately 25%; Check Out 20 Stocks Making Moves in Premarket Trading

Dec 16 2025Benzinga

UiPath Shares Rise Approximately 9%; Check Out 20 Stocks Making Moves in Premarket Trading

Dec 04 2025Benzinga

Immuron Secures US Military Contract for New Oral Therapeutics Targeting Campylobacter and Shigella

Dec 03 2025Globenewswire

Immuron Secures US Military Contract for Oral Therapeutics Development Targeting Campylobacter and Shigella

Dec 03 2025Newsfilter

FDA Grants IND Approval for Immuron's IMM-529

Nov 05 2025Newsfilter

Immuron Receives FDA Approval for IND Application of IMM-529

Nov 05 2025NASDAQ.COM

Immuron Provides Update on Clinical Trial Progress

Oct 31 2025Newsfilter

Join the Live Stream of Day 1 at the Emerging Growth Conference 87 on October 22. Register Now!

Oct 20 2025Globenewswire

Immuron Reports Increase in Global Revenue for First Quarter

Oct 13 2025NASDAQ.COM

Immuron Reports Year-Over-Year Growth for Q1 FY26

Oct 13 2025Newsfilter

What’s Driving Immuron's Pre-market Surge?

Oct 08 2025NASDAQ.COM

Join the Live Stream of Day 1 at the Emerging Growth Conference 85 on August 20; Registration Now Open

Aug 18 2025Globenewswire

Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket

Jul 18 2025Benzinga